Pfizer: BofA Global Research raises price objective to $29 from $27
PFE•BofA Global Research raised its price objective for Pfizer to $29 from $27.
Related News
BofA Global Research cuts Revolution Medicines price objective to $264 from $265
RVMD•
BofA Global Research raises Novavax price objective to $8 from $7
NVAX•
UBS lifts AbbVie target as focus expands beyond immunology drugs
ABBV•
Keysight to showcase AI infrastructure validation portfolio at OCP Global Summit
KEYS•
Saba Capital Management reports $12,664 purchase of New Germany Fund common shares
GF•